GLENN L. COOPER, M.D.

Corporate Board Profile

Tech Score: 0/100

REPLIGEN CORP

Filing Date	Source Excerpt
2010-07-28	Glenn L. Cooper, M.D. has served as a Director of Repligen since August 2009 and is currently a private investor. Dr. Cooper served as the Chairman and Chief Executive Officer of Indevus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on urology and endocrinology, from 2000 to 2009 and as Chief Executive Officer and Director from 1993 to 2000. Prior to joining Indevus in 1993, Dr. Cooper held numerous executive level positions including President and Chief Executive Officer of Progenitor, Inc., Executive Vice President and Chief Operating Officer of Sphinx Pharmaceuticals Corporation, and various clinical and regulatory positions with Eli Lilly and Company. Dr. Cooper received an M.D. from Tufts University School of Medicine, performed his postdoctoral training in Internal Medicine and Infectious Diseases at the New England Deaconess Hospital and the Massachusetts General Hospital and received a B.A. from Harvard College.
2011-07-29	Glenn L. Cooper, M.D. has served as a Director of Repligen since August 2009 and is currently the Executive Chairman of Coronado BioSciences, Inc. ... Dr. Cooper received an M.D. from Tufts University School of Medicine.

Filing Date

Source Excerpt

2010-07-28

Glenn L. Cooper, M.D. has served as a Director of Repligen since August 2009 and is currently a private investor. Dr. Cooper served as the Chairman and Chief Executive Officer of Indevus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on urology and endocrinology, from 2000 to 2009 and as Chief Executive Officer and Director from 1993 to 2000. Prior to joining Indevus in 1993, Dr. Cooper held numerous executive level positions including President and Chief Executive Officer of Progenitor, Inc., Executive Vice President and Chief Operating Officer of Sphinx Pharmaceuticals Corporation, and various clinical and regulatory positions with Eli Lilly and Company. Dr. Cooper received an M.D. from Tufts University School of Medicine, performed his postdoctoral training in Internal Medicine and Infectious Diseases at the New England Deaconess Hospital and the Massachusetts General Hospital and received a B.A. from Harvard College.

2011-07-29

Glenn L. Cooper, M.D. has served as a Director of Repligen since August 2009 and is currently the Executive Chairman of Coronado BioSciences, Inc. ... Dr. Cooper received an M.D. from Tufts University School of Medicine.

Data sourced from SEC filings. Last updated: 2025-07-01